LNTH vs RDNT
LNTH: Lantheus Holdings is a medical technology leader specializing in diagnostic imaging and targeted radiopharmaceutical therapies for oncology and cardiovascular care. RDNT: Leading operator of multi-modality diagnostic imaging centers across the US, with integrated AI-powered radiology software and digital health solutions.
Side-by-side fundamentals
| Metric | LNTH | RDNT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $104.61 | $59.22 | |
| Market cap as of 2026-07-23 | $6.8B | $4.8B | |
| P/E as of 2026-07-23 | 24.55 | n/a | |
| PEG as of 2026-07-23 | 1.47 | n/a | |
| Net margin as of 2026-07-23 | +18.1% | -0.7% | LNTH higher |
| Gross margin as of 2026-07-23 | +60.5% | +24.1% | LNTH higher |
| Operating margin as of 2026-07-23 | +22.6% | +2.9% | LNTH higher |
| ROE as of 2026-07-23 | +24.3% | -1.4% | LNTH higher |
| ROA as of 2026-07-23 | +12.4% | -0.4% | LNTH higher |
| Debt / equity as of 2026-07-23 | 0.47 | 1.01 | LNTH lower |
| Revenue growth (YoY) as of 2026-07-23 | +0.6% | +14.7% | RDNT higher |
| Revenue CAGR (3y) SEC XBRL | +18.1% | +12.6% | LNTH higher |
| Beta as of 2026-07-23 | -0.01 | 1.41 | |
| 1-year return as of 2026-07-22 close | +44.6% | +3.6% | LNTH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.